ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements with these filters
Swati Ghosh has been regularised as a Non-Executive Independent Director at Stallion India Fluorochemicals Limited. This designation change was effective from September 21, 2026.
Stallion India Fluorochemicals held its 24th AGM on September 21, 2026, to discuss financial statement adoption and director appointments. Official results will be disclosed separately.
Stallion India Fluorochemicals has commenced commercial operations at its new Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra. The plant has an aggregate annual capacity of 1,200 MT.
Stallion India Fluorochemicals Ltd has filed its Annual Report for FY 2025-26 and notified the cut-off date for its 24th Annual General Meeting.
Stallion India Fluorochemicals Limited has issued a notice for its 24th Annual General Meeting, scheduled to be held on September 21, 2026.
Stallion India Fluorochemicals delivered strong Q1 FY27 results with Revenue at ₹124.68 cr (up 12.78% YoY). Strategy focuses on backward integration through new R32 and HFO plants to boost margins.
Stallion India reports strong Q1 FY27 results with 79% PAT growth. Strategy shifts toward high-margin specialty gases and backward integration through a new 10,000 MT R-32 plant.
Stallion India Fluorochemicals reported Q1 FY27 results, with revenue growing 12.78% to ₹124.68 Crore and PAT surging 79.15% to ₹18.57 Crore.
Stallion India Fluorochemicals filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of IPO proceeds.
Stallion India Fluorochemicals Ltd reported revenue from operations of ₹121.4 Cr (+9.9% YoY) and net profit of ₹18.6 Cr (+78.8% YoY) for Q1 FY27.
Stallion India Fluorochemicals Limited will hold a board meeting on 12-Aug-2026 to consider and approve its unaudited financial results for the quarter ended June 2026.
Stallion India Fluorochemicals Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Neomile Corporate Advisory and associated funds sold a 2.53% stake in Stallion India Fluorochemicals via the open market. Their remaining aggregate holding stands at 9.86%.
Stallion India Fluorochemicals Limited shareholders approved a special resolution for variation in IPO proceeds objects. The resolution passed with a 99.99% majority via postal ballot.
Stallion India reports strong FY26 performance with revenue of ₹434.12 Cr and PAT growth of 35.61%. Strategy focuses on backward integration into R-32 manufacturing and expansion into specialty/semiconductor gases.
Stallion India Fluorochemicals filed its quarterly monitoring report for its ₹160.73 Crore IPO. The company reported material deviations in issue expenses and working capital utilization.
Stallion India Fluorochemicals submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no adverse observations.
Stallion India Fluorochemicals reported FY26 revenue growth of 14.40% to ₹434.12 Crore. PAT increased 35.61%, driven by strategic preparedness and operational resilience.
Stallion India Fluorochemicals appointed Ms. Swati Ghosh as an Independent Director for five years. Her secretarial expertise will strengthen board compliance and regulatory oversight.
Stallion India Fluorochemicals Ltd reported revenue from operations of ₹110 Cr (-27.4% YoY) and net profit of ₹10.9 Cr (-18.0% YoY) for Q4 FY26.
Stallion India reported a net profit of ₹43.74 Crore for FY2026. The board also appointed Ms. Swati Ghosh as an Independent Director for five years.
Stallion India Fluorochemicals will hold a board meeting on May 13, 2026. Directors will review and approve audited standalone financial results for fiscal 2026.
Stallion India Fluorochemicals Limited has published newspaper advertisements in Free Press Journal and Navshakti confirming the dispatch of its Postal Ballot Notice. The notice informs shareholders and stakeholders of the ongoing postal ballot process in compliance with regulatory requirements.
Stallion India Fluorochemicals Limited has issued a Postal Ballot notice to shareholders. The company seeks approval via special resolution for a variation in the terms of the Objects of the Issue related to its IPO proceeds. Voting is scheduled to conclude on May 30, 2026.
Stallion India Fluorochemicals Limited has issued a Postal Ballot notice to shareholders. The company seeks approval via a Special Resolution for the variation in terms of the Objects of the Issue (IPO proceeds). The voting period ends on May 30, 2026.
Stallion India Fluorochemicals Ltd issued a postal ballot notice seeking shareholder approval to vary IPO proceeds utilization. The proposal involves reallocating ₹160.73 Crore, including acquiring land at Khalapur for ₹7.80 Crore instead of constructing a warehouse. The variation aims to enhance long-term expansion capabilities and operational efficiency.
Stallion India Fluorochemicals Limited clarified to stock exchanges that recent share price movements are market-driven. The company confirmed all material disclosures, including land allotments in Rajasthan and a helium sourcing partnership in Qatar, have been timely reported. It further stated no unpublished price-sensitive information is currently pending announcement.
Shri Gautam Lath has resigned as an Independent Director of Stallion India Fluorochemicals Limited effective April 20, 2026, citing increasing professional commitments. He has also stepped down from all board committees. The director confirmed there are no other material reasons for his departure. The company has filed the necessary intimations with the stock exchanges.
Stallion India Fluorochemicals Limited has appointed M/s. Himani R. Patel & Associates as Internal Auditor for a 12-month term starting April 1, 2026. The firm will provide audit and taxation services. This appointment ensures compliance with internal governance and financial oversight standards.
Stallion India Fluorochemicals Limited has appointed M/s. Himani R. Patel & Associates, Chartered Accountants, as its Internal Auditor for the Financial Year 2026-27. The appointment was approved by the Board on April 20, 2026, following the Audit Committee's recommendation. The firm will provide audit and taxation services to ensure regulatory compliance.